Quetiapine, sold under the brand name Seroquel among others, is an atypical antipsychotic medication used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder.
| FactSnippet No. 626,354 |
Quetiapine, sold under the brand name Seroquel among others, is an atypical antipsychotic medication used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder.
| FactSnippet No. 626,354 |
Quetiapine is believed to work by blocking a number of receptors including serotonin and dopamine.
| FactSnippet No. 626,355 |
Quetiapine was developed in 1985 and approved for medical use in the United States in 1997.
| FactSnippet No. 626,356 |
Quetiapine is primarily used to treat schizophrenia or bipolar disorder.
| FactSnippet No. 626,357 |
Quetiapine is effective when used by itself and when used along with other medications in major depressive disorder.
| FactSnippet No. 626,358 |
Quetiapine has fewer extrapyramidal side effects and is less likely to cause hyperprolactinemia when compared to other drugs used to treat schizophrenia, so is used as a first line treatment.
| FactSnippet No. 626,359 |
Quetiapine is excreted primarily via the kidneys and in feces after hepatic metabolism, the remainder is excreted as the drug in its unmetabolized form.
| FactSnippet No. 626,360 |
Quetiapine is a tetracyclic compound and is closely related structurally to clozapine, olanzapine, loxapine, and other tetracyclic antipsychotics.
| FactSnippet No. 626,361 |
Quetiapine has not provided a reason for the delay of Seroquel XR's launch.
| FactSnippet No. 626,362 |
Quetiapine received its initial indication from U S FDA for treatment of schizophrenia in 1997.
| FactSnippet No. 626,363 |